POPULATION HEALTH VALUE OF BEING IN TARGET: RESULTS FROM THE CANADIAN MULTI-MORBIDITY MODEL FOR TYPE 2 DIABETES

Abstract

Diabetes affects nearly 10% of Canadians, and can lead to many diabetes-related complications. Novel therapies purport to both improve control of diabetes and reduce the risk of these complications. Microsimulation modelling allows for the synthesis of multiple data sources for comparative effectiveness analysis related to a variety of correlated outcomes. However, existing type 2 diabetes models often use data that are decades old, are derived using non-representative clinical trial populations, or do not fully model vascular risk.